Safety of cetirizine in infants 6 to 11 months of age: A randomized, double-blind, placebo-controlled study

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1244-1248

  Simons, F Estelle R ^a,e   Silas, Peter ^b   Portnoy, Jay M ^c   Catuogno, Joseph ^d   Chapman, Douglass ^d   Olufade, Abayomi O ^d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Wee Care Pediatrics   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d PFIZER INC   (United States)

^e NONE   (Canada)

Author keywords

Cetirizine; Early treatment of the atopic child; Electrocardiogram; H1 antihistamine; Infant; Somnolence

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; PLACEBO;

AGITATION; ALLERGIC DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG SCREENING; FEMALE; FEVER; HEART DISEASE; HUMAN; INFANT; INSOMNIA; IRRITABILITY; MALE; NERVOUSNESS; OTITIS MEDIA; PHARYNGITIS; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINITIS; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TOOTH PAIN; TREATMENT OUTCOME; TREMOR; UPPER RESPIRATORY TRACT INFECTION;

EID: 0037504116     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1496     Document Type: Article

References (33)

1. 1-antihistamines in allergic disease. New York: Marcel Dekker, Inc; 2002. p. 437-64.
2. Spencer CM, Noble S. Cetirizine: a review of its use in children with allergic disorders. Paediatr Drugs 1999;1:51-73.
3. 1-receptor antagonist cetirizine in very young children with atopic dermatitis. J Allergy Clin Immunol 1999;104:433-40.
4. 1-receptor antagonist cetirizine on the behavioral, cognitive and psychomotor development of very young children with atopic dermatitis. Pediatr Res 2002;52:251-7.
5. de Longueville M, Deruyter B. RR, QT, and QTc in 799 infants aged 1-2 years. J Allergy Clin Immunol 1998;101:S198.
6. Ridout SM, Tariq SM. Cetirizine overdose in a young child. J Allergy Clin Immunol 1997;99:860-1.
7. Diepgen TL on behalf of the ETAC Study Group. Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC® trial) over 18 months. Pediatr Allergy Immunol 2002;13:278-86.
8. Simons FER on behalf of the ETAC Study Group. Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol 2001;107:703-6.
9. Warner JO on behalf of the ETAC Study Group. A double-blind, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' post-treatment follow-up. J Allergy Clin Immunol 2001;108:929-37.
10. Spicak V, Dab I, Hulhoven R, Desager JP, Klanova M, de Longueville M, et al. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers. Clin Pharmacol Ther 1997;61:325-30.
11. Groswasser J, Brusquet Y, Cornus A, Saké J-K, de Longueville M, Kahn A. Effects of cetirizine in night polygraphic recording in infants. Pediatr Allergy Immunol 1995;6(suppl 8):96.
12. Sagie A, Larson MG, Goldberg RJ, Bengston JR, Levy D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992;70:797-801.
13. 1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography. Methods Find Exp Clin Pharmacol 1993;15:183-8.
14. 1 antagonist. Neuropediatrics 1998;29:320-1.
15. Skoner DP. Complications of allergic rhinitis. J Allergy Clin Immunol 2000;105:S605-9.
16. Simons FER. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996;17:185-9.
17. Emerson RM, Williams HC, Allen BR. What is the cost of atopic dermatitis in preschool children? Br J Dermatol 2001;144:514-22.
18. Daud LR, Garralda ME, David TJ. Psychosocial adjustment in preschool children with atopic eczema. Arch Dis Child 1993;69:670-6.
19. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, Sampson HA, Lupo M. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995;149:856-60.
20. Reuveni H, Chapnick G, Tal A, Tarasiuk A. Sleep fragmentation in children with atopic dermatitis. Arch Pediatr Adolesc Med 1999;153:249-53.
21. Wyngaarden JB, Seevers MH. The toxic effects of antihistaminic drugs. JAMA 1951;145:277-82.
22. Magera BE, Betlach CJ, Sweatt AP, Derrick CW Jr. Hydroxyzine intoxication in a 13-month-old child. Pediatrics 1981;67:280-3.
23. Garza MB, Osterhoudt KC, Rutstein R. Central anticholinergic syndrome from orphenadrine in a 3-year-old. Pediatr Emerg Care 2000;16:97-8.
24. Lindsay CA, Williams GD, Levin DL. Fatal adult respiratory distress syndrome after diphenhydramine toxicity in a child: a case report. Crit Care Med 1995;23:777-81.
25. Kahn A, Bium D. Phenothiazines and sudden infant death syndrome. Pediatrics 1982;70:75-8.
26. Hickson GB, Altemeier WA, Clayton EW. Should promethazine in liquid form be available without prescription? Pediatrics 1990;86:221-5.
27. Ponsonby A-L, Dwyer T, Couper D. Factors related to infant apnoea and cyanosis: a population-based study. J Paediatr Child Health 1997;33:317-23.
28. Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over-the-counter cough and cold medications. Pediatrics 2001;108:e52.
29. Jumbelic MI, Hanzlick R, Cohle S. Alkylamine antihistamine toxicity and review of pediatric toxicology registry of the National Association of Medical Examiners. Am J Forensic Med Patrol 1997;18:65-9.
30. de Benedictis FM, Forenza N, Armenio L, Boner AL, Giorgi PL, del Giudice MM, et al. Efficacy and safety of cetirizine and oxatomide in young children with perennial allergic rhinitis: a 10-day, multicenter, double-blinded, randomized, parallel-group study. Pediatr Asthma Allergy Immunol 1997;11:119-28.
31. Baelde Y, Dupont P. Cetirizine in children with chronic allergic rhinitis. A multicentre double-blind study of two doses of cetirizine and placebo. Drug Invest 1992;4:466-72.
32. Allegra L, Paupe J, Wieseman HG, Baelde Y. Cetirizine for seasonal allergic rhinitis in children aged 2-6 years. A double-blind comparison with placebo. Pediatr Allergy Immunol 1993;4:157-61.
33. Salmun LM, Herron JM, Banfield C, Padbi D, Lorber R, Affrime MB. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther 2000;22:613-21.